Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023738 · ClinicalTrials.gov registry record · Phase 1
Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
A Phase 1 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00023738: Completed Phase 1 study, sponsored by Radiation Therapy Oncology Group.
NCT00023738 is a Phase 1 study that has completed, run by Radiation Therapy Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00023738, a Phase 1 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Drugs such as SU5416 may stop the growth of cancer by stopping blood flow to the tumor. Radiation therapy uses high-energy x-rays to damage tumor cells. Giving chemotherapy, SU5416, and radiation therapy before and after surgery may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of chemotherapy, SU5416, radiation therapy, and surgery in treating patients who have soft tissue sarcoma.
Interventions
- DRUG ifosfamide
- DRUG dacarbazine
- BIOLOGICAL filgrastim
- DRUG doxorubicin hydrochloride
- DRUG semaxanib
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-08 |
| Est. Completion | 2003-10 |
| Phase | Phase 1 |
What the finished NCT00023738 record still lists
NCT00023738 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which ifosfamide is the first listed.
NCT00023738 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00023738 about?
NCT00023738 is a clinical study titled "Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Drugs such as SU5416 may stop the growth of cancer by stopping blood flow to the tumor. Radiation therapy uses high-energy x-rays to damage tumor cells. Giving chemotherapy, SU5416...
What is the current status of trial NCT00023738?
This trial is currently completed. It is a Phase 1 study. The study started on 2001-08. Estimated completion is 2003-10.
What interventions are being tested in trial NCT00023738?
The interventions under investigation include: ifosfamide (DRUG), dacarbazine (DRUG), filgrastim (BIOLOGICAL), doxorubicin hydrochloride (DRUG), semaxanib (DRUG).
Who is sponsoring clinical trial NCT00023738?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia